{"id":558746,"date":"2026-06-12T02:00:00","date_gmt":"2026-06-12T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/enfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay\/"},"modified":"2026-06-17T11:00:43","modified_gmt":"2026-06-17T09:00:43","slug":"enfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/enfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay\/","title":{"rendered":"Enfoques terap\u00e9uticos innovadores para la CBP, la CSP y la HAI: \u00bfqu\u00e9 novedades hay?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Los agonistas del PPAR como tratamiento de segunda l\u00ednea han demostrado su eficacia en la colangitis biliar primaria (CBP), no solo en ensayos cl\u00ednicos, sino tambi\u00e9n en el entorno cl\u00ednico real, tal y como muestran los resultados de investigaciones recientes. En el caso de la colangitis esclerosante primaria (PSC), el \u00e1cido nor\u00falico (NCA) mejor\u00f3 los par\u00e1metros anal\u00edticos relevantes y mostr\u00f3 efectos hepatoprotectores. En cuanto a la hepatitis autoinmune (HAI), en un an\u00e1lisis reciente se ha evaluado el rendimiento del micofenolato mofetilo en comparaci\u00f3n con la azatioprina, ambos en combinaci\u00f3n con prednisolona.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fenfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Los agonistas del PPAR como tratamiento de segunda l\u00ednea han demostrado su eficacia en la colangitis biliar primaria (CBP), no solo en ensayos cl\u00ednicos, sino tambi\u00e9n en el entorno cl\u00ednico&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fenfoques-terapeuticos-innovadores-para-la-cbp-la-csp-y-la-hai-que-novedades-hay%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":558748,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Enfermedades hep\u00e1ticas autoinmunes  ","footnotes":"[{\"content\":\"<em>Criterios de respuesta del estudio POISE = ALP [fosfatasa alcalina] <1,67 veces el l\\u00edmite superior del rango normal (ULN), as\\u00ed como una reducci\\u00f3n del 15 % en la ALP y una bilirrubina total dentro de los valores normales al cabo de 1 a\\u00f1o.  <\\\/em>\",\"id\":\"4b3154c2-2e71-44d9-b2fc-5c3e68c86fac\"},{\"content\":\"<em>ULN (upper limit of normal) = l\\u00edmite superior del rango normal<\\\/em>\",\"id\":\"85539fe2-6d0e-4c82-9a2e-85cb9bf78fe2\"}]"},"category":[11552,11483,11475,11358,11288],"tags":[94760,94758,72845,14393,32594,32596,72850,63783,94763,94762,32595,27686,32597,11944],"powerkit_post_featured":[],"class_list":["post-558746","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-es","category-el-congreso-informa","category-estudios","category-gastroenterologia-y-hepatologia","category-medicina-interna-general","tag-acido-norulico","tag-agonistas-de-los-ppar","tag-aih-es","tag-azatioprina-es","tag-colangitis-biliar-primaria","tag-colangitis-esclerosante-primaria","tag-enfermedades-hepaticas-autoinmunes","tag-hepatitis-autoinmune","tag-micofenolato-mofetilo-2","tag-nca","tag-pbc-es","tag-prednisolona","tag-psc-es","tag-terapia-de-segunda-linea","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-27 03:50:14","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/558746","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=558746"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/558746\/revisions"}],"predecessor-version":[{"id":558750,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/558746\/revisions\/558750"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/558748"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=558746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=558746"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=558746"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=558746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}